ArticleBMJ open2026

Efficacy and safety of risk-stratified chemotherapy with azacitidine for children with myeloid leukaemia with Down syndrome: protocol for a multicentre phase II trial (JCCG AML-D24).

Kentaro Nakashima et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.